Skip to content

Updates

Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.

Type
Blogs Testimonial
Sectors (2)
Agriculture Biotech Chemicals Cosmetics Diagnostics Digital Health Food and Feed Healthcare Medical Devices Pharmaceuticals
Expertises (1)
Advertising and Claims Commercial Contracts Corporate, Governance and Boardroom Counselling Data Protection, (Cyber)security and AI Due Diligence Environmental and Sustainability Financing and M&A Intellectual Property and Licensing Litigation Regulatory Compliance and Enforcement Spin-out and Starter Advisory Subsidies and Grants
Medical Devices Remove filter Biotech Remove filter Due Diligence Remove filter Clear all

4 results

Newest first
Newest first Oldest first A–Z Z–A
Food and Feed Medical Devices Pharmaceuticals Due Diligence Testimonial

Axon regularly acts as a sub-contractor for leading international firms to assist in regulatory due diligence in our fields of expertise: pharma, medical technology and food.

Biotech Food and Feed Due Diligence Regulatory Compliance and Enforcement Testimonial

Axon assisted a French VC company investing in a food tech start-up. We reviewed the target’s regulatory strategy under the EU novel foods framework, assessed its feasibility and outlined potential risks and how to mitigate these.

Medical Devices Data Protection, (Cyber)security and AI Due Diligence Regulatory Compliance and Enforcement Testimonial

We have conducted regulatory due diligence on behalf of a private equity firm in connection with the acquisition of a medical device manufacturer, covering MDR compliance (including notified body certificates and post-market surveillance obligations), as well as data protection aspects.

Biotech Diagnostics Corporate, Governance and Boardroom Counselling Due Diligence Financing and M&A Testimonial

Axon acted on behalf of an investor in connection with their investment in a clinical-stage biotech company developing first-in-class therapeutics and diagnostics for fibrosis. We conducted legal due diligence on the target company and reviewed the transaction documentation on behalf of the investors.